• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A benzothiazepine derivative of the formula: wherein R is hydrogen or acetyl, is prepared by condensing a compound of the formula: wherein R is the same as defined above, with 2-(dimethylamino)-ethyl halide (i) in the presence of potassium hydroxide in acetone; or (ii) in the presence of potassium carbonate in acetone, lower alkyl acetate, a mixture of acetone and water or a mixture of lower alkyl acetate and water.
    公开号:SU1176839A3
    申请号:SU823524316
    申请日:1982-12-06
    公开日:1985-08-30
    发明作者:Гайно Мицунори；Иидзима Икуо；Нисимото Сигеру；Икеда Куитиро；Фудзии Токуо
    申请人:Танабе Сейяку Ко,Лтд (Фирма)；
    IPC主号:
    专利说明:

    11 The invention relates to organic chemistry, namely to methods for producing benzothiazepine derivatives which can be used as a means of expanding the coronary vessels. The purpose of the invention. The simplification of the process for the production of pro-. aqueous benzotnazepine, which are used in medicine. Example 1o A mixture of 30.1 g of cis- ((4-toxifensh1) -3-hydroxy-2,3-digo-1,5-benzothiazepin-4 (5H) -one, 17.8 g of 2-dimethylaminoethyl chloride hydrochloride, 13.7 g of a 96% potassium hydroxide solution, 60 g of sodium sulfate and 300 ml of acetone were stirred at 50 for 7 hours. After the reaction was completed, the mixture was filtered to remove inorganic materials, and the filtrate was condensed The residue is dissolved in ethanol. After the solution is cooled, a mixture of 10% HCl ethanol is added to the solution. The crystalline precipitate is collected by filtration and then dried. 35.1 g of cis - (+) - 2- (4-labels iphenyl) -3-hydroxy-5- (2-dimesh1aminoethyl) -2,3-dihydro-1,5-benzothiazepin-4 (hydrochloride. Output 86.2%, t „pLo225-227 ° С (decomposed) Oil 1 7oos.otO / - t „Example2o A mixture of 30.1 g of cis ((4-methoxyphenyl-3-hydroxy-2, 3-dihydro-1,5-benzothiazepin-4 (5H) MDHa, 17j2 g of hydrochloride with 2-dimethyl but ethyl chloride, 31.8 g of potassium carbonate and 240 ml of acetone are refluxed for 30 minutes with stirring. Then 10 ml of water are added to the mixture and the aqueous mixture is then refluxed for 3 hours with stirring. After the reaction is complete, the mixture is evaporated under reduced pressure to remove acetone. The residue is dissolved in toluene and the solution is washed twice with water. The toluene layer is collected and then evaporated under reduced pressure to remove toluene. The residue is dissolved in ethanol. After cooling, the solution is acidified with a mixture of 10% HC1 - ethanol and then stirred at a temperature below for 5 hours. The crystalline precipitate is collected by filtration, washed with ethanol, and then dried. 37.1 cis- (+) -2- (4-methoxyphenll) -3-hydroxy-5-2-dimethylamino, 3-dihydro-1,5-benzothiazepine 9 4 (5H} -one hydrochloride is dissolved; yield 90, 7%, mp.225-227 C (decomposition .. Prize. A mixture of 30.1 g of hydrochloride cis - (+) - 2- (4-methoxyphenyl) 3-hydroxy-2, 3-dihydro-1,5- benzothiazepine4 (, 18.7 g of 2dn-methylaminoethyl chloride hydrochloride, 33.0 g of potassium carbonate and 240 ml of ethyl acetate D-jimine out for 30 minutes while stirring. Then 5 ml of water and the mixture are added to the mixture, refluxed for 6 hours with stirring After cooling the reaction mixture, the mixture is washed with water, the ethyl acetate layer is separated, washed water is then evaporated under reduced pressure to remove ethyl acetate. The residue is dissolved in ethanol. After cooling, the solution is acidified with a mixture of 10% HC1 - ethanol, then stirred at a temperature below 10 ° C for 5 hours. The crystalline precipitate is collected by filtration, washed with ethanol and dried, 37.9 cis - (+) - 2- (4-methoxyphenyl-3-hydroxy-5-2-dimethylaminoethyl -2, 3-dihydro-1.5-benzothiazepin-4 (5H) -one hydrochloride is obtained. The output of 92.7%, so pl. 225-227 ° C (decomposition). Example 4. To a mixture of 30.1 g of cis- () -2- (4-methoxyphenyl-3-hydroxy-2, 3-dihydro-1,5-benzothiazhesh-4) (, 34.5 g of powdered potassium carbonate and 300 / .yl acetone are added 18.7 g of 2-dimethyl aminoethyl chloride hydrochloride at room temperature with stirring. The mixture is refluxed for 9 hours with stirring. After cooling, the mixture is evaporated to remove acetone. The residue is dissolved in ethyl acetate and the solution is washed with water, dried and evaporated to remove ethyl acetate. The residue is dissolved in methanol. After cooling, the solution is acidified with a mixture of 10% C1 is ethanol and then evaporated to remove the solvent. The residue is recrystallized from isopropanol to give 38.64 g of cis - (+) - 2- (4-methoxyphenyl) -3-hydroxy-5- (2-dimethyl aminoethyl) -2 , 3-dngydro-1,5-benzothiazepin-4 (5H) -one hydrochloride. 225-221 C output 94.5%, TopPL false.) Example 5 "In a mixture of 30.1 g cis -, (+) - 2- (4-methoxyphenyl) -3-hydroxy
    权利要求:
    Claims (1)
    [1]
    cl. 260-239.3, published, 1972. (5YU (5T) METHOD FOR PRODUCING BENZOTIAZEPINE DERIVATIVES of the general formula
    CH g CH g B (CH 3 ) g where R is a hydrogen atom or acetyl, using the derivative 2- (4-. Methoxyphenyl) -2,3-dihydro-1,5-benzothiazepin-4 (5H) -one, hydrochloride '2-dimethylaminoethyl chloride, a base and an organic solvent when heated, characterized in that, in order to simplify the process technology, a compound of general form, where £ has the indicated meaning, is reacted with 2-dimethylaminoethyl chloride hydrochloride in the presence of caustic potassium in acetone or in the presence of carbonate potassium in acetone, lower alkyl acetate, or a mixture thereof with water. from 30 ° C to the boiling point of the reaction mixture.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1176839A3|1985-08-30|Method of producing derivatives of benzotiazepine
    CA1272717A|1990-08-14|Naphthothiazepinones
    JP2619280B2|1997-06-11|Optical resolution of racemic acid
    SU873887A3|1981-10-15|Method of preparing derivatives of imidazo-/2,1-b/-thiazoline or imidazo-/2,1-b-thiazine or their acid-additive salts in form of isomer mixture or individual isomers
    US7329318B2|2008-02-12|Methods of crystal precipitation
    KR970002466B1|1997-03-05|Process for preparing 1,5-benzothiazepine derivatives
    JP4688383B2|2011-05-25|Method for producing dibenzothiazepine derivatives
    CA1223585A|1987-06-30|Process for the preparation of benzothiazepinederivatives
    EP0702009B1|1998-07-01|Method for the preparation of pharmaceutically active benzothiazepine derivatives
    US4864058A|1989-09-05|Process for making optically active naphtho[1,2-b][1,4]thiazepin-4|-ones
    RU2139853C1|1999-10-20|Method of preparing dilthiazem
    KR910002879B1|1991-05-09|Process for preparing 1,5-benzothiazepin derivatives
    SU497764A3|1975-12-30|The method of obtaining derivatives of norbornane
    US5225557A|1993-07-06|Process for making optically active naphtho[1,2-b]thiazepin-4|-ones
    AU594137B2|1990-03-01|Naphthothiazocinones
    US5705638A|1998-01-06|Process for preparing optically active 3-hydroxy-1,5-benzothiazepine derivative and intermediate therefor
    US4996352A|1991-02-26|Enantiomers of β-[| thiol]-α-hydroxy-4-methoxybenzene propanoic acid
    US4062851A|1977-12-13|Process for the resolution of certain octahydrobenzocycloheptapyridoisoquinolinols
    CA1337346C|1995-10-17|Process for preparing 1,5-benzothiazepine derivatives
    JPH05202013A|1993-08-10|Preparation of 1,5-benzothiazepine derivative
    US5055575A|1991-10-08|Process for preparing 1,5-benzothiazepine derivatives
    SK5602000A3|2000-09-12|CONVERSION METHOD OF TREO-|-2-HYDROXY-3-| -AMINOPHENYLTHION)-3-|PROPIONIC ACID DERIVATIVES,ì DILTIAZEM MADE FROM THESE INTERMEDIATES
    SU430554A1|1974-05-30|Method of producing 2,3-benzoxazepine derivatives
    KR100297802B1|2001-11-05|Method for preparing 2- | anilinonicotinic acid 2- | ethyl.
    BE728862A|1969-08-01|
    同族专利:
    公开号 | 公开日
    EP0081234A1|1983-06-15|
    BG38937A3|1986-03-14|
    ES517966A0|1984-01-01|
    US4438035A|1984-03-20|
    FI79705B|1989-10-31|
    IE822836L|1983-06-07|
    ES8401953A1|1984-01-01|
    JPS6317832B2|1988-04-15|
    KR840002819A|1984-07-21|
    DE3266583D1|1985-10-31|
    AT15799T|1985-10-15|
    JPS5899471A|1983-06-13|
    HU187431B|1986-01-28|
    EP0081234B1|1985-09-25|
    FI824165L|1983-06-08|
    FI824165A0|1982-12-03|
    CA1177075A|1984-10-30|
    FI79705C|1990-02-12|
    KR860002034B1|1986-11-17|
    DK540382A|1983-06-08|
    DK154022B|1988-10-03|
    IE54241B1|1989-08-02|
    HK95488A|1988-12-02|
    DK154022C|1989-02-20|
    US4438035B1|1994-07-26|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3075967A|1961-06-12|1963-01-29|Olin Mathieson|Benzothiazines|
    US3562257A|1967-10-28|1971-02-09|Tanabe Seiyaku Co|Benzothiazepine derivatives|
    JPS57106673A|1980-12-24|1982-07-02|Chugai Pharmaceut Co Ltd|Dibenzooxazepin derivative|GB8316032D0|1983-06-11|1983-07-13|Tanabe Seiyaku Co|Benzothiazepine derivatives|
    IT1206505B|1983-07-22|1989-04-27|Schiapparelli Farma|NEW BENZOTHIAZEPINONIC DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.|
    GB2154577A|1984-02-18|1985-09-11|Tanabe Seiyaku Co|1,5-benzothiazepines|
    IL71538A|1984-04-13|1987-07-31|Abic Ltd|Process for the preparation of benzothiazepine derivatives|
    US4758954A|1984-07-25|1988-07-19|Computer Services Corporation|Method of adjusting ticket fares|
    US4652561A|1986-02-26|1987-03-24|Hoffmann-La Roche Inc.|Naphtho[1,2-b]-1,4-thiazepinones|
    IL81954D0|1986-03-24|1987-10-20|Hoffmann La Roche|Naphthothiazocinones,their manufacture and pharmaceutical compositions containing them|
    US4871731A|1987-10-07|1989-10-03|Marion Laboratories, Inc.|Captopril and diltiazem composition and the like|
    US4808580A|1987-12-17|1989-02-28|Hoffmann-La Roche Inc.|Naphtho[1,2-b][1,4]thiazepin-4-ones and use thereof in treatment of ischemia and blood pressure lowering|
    IT1226301B|1988-07-26|1990-12-27|Zambon Spa|PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR THE SYNTHESIS OF DILTIAZEM.|
    FR2641535B1|1989-01-11|1991-03-15|Synthelabo|PROCESS FOR THE PREPARATION OF--HYDROXY-3-2 DIHYDRO-2,3 5H-BENZOTHIAZEPINE-1,5 ONE-4|
    USRE34935E|1989-01-11|1995-05-09|Synthelabo|Method for preparing --3-hydroxy-2--2,3-dihydro-5H-1,5-benzothiazepine-4-one and chlorinated derivatives thereof|
    US5128469A|1989-04-28|1992-07-07|Tanabe Seiyaku Co., Ltd.|Process for preparing 1,5-benzothiazepine derivatives|
    JPH085869B2|1990-03-08|1996-01-24|田辺製薬株式会社|Process for producing 1,5-benzothiazepine derivative|
    NL9000763A|1990-03-31|1991-10-16|Stamicarbon|PROCESS FOR PREPARING 1,5-BENZOTHIAZEPINE DERIVATIVES.|
    IT1255545B|1992-10-23|1995-11-09|PROCEDURE FOR THE PREPARATION OF DILTIAZEM|
    DK0702009T3|1994-09-16|1999-02-01|Orion Corp Fermion|Process for the preparation of pharmaceutically active benzothiazepine derivatives|
    FI97725C|1995-02-17|1997-02-10|Orion Yhtymae Oy|Method for preparing diltiazem|
    WO1996038429A1|1995-06-01|1996-12-05|AcicInc.|Method for the manufacture of benzothiazepine derivatives|
    US5559229A|1995-06-01|1996-09-24|AcicInc.|Method for the manufacture of benzothiazepine|
    CA2197816A1|1996-02-23|1997-08-24|Tanabe Seiyaku Co., Ltd.|Process for preparing 1,5-benzothiazepine derivative|
    TW438787B|1997-02-27|2001-06-07|Tanabe Seiyaku Co|Process for preparing optically active trans-3-substituted glycidic acid ester|
    US6635277B2|2000-04-12|2003-10-21|Wockhardt Limited|Composition for pulsatile delivery of diltiazem and process of manufacture|
    US11241379B2|2015-12-01|2022-02-08|Sun Pharmaceutical Industries Limited|Parenteral dosage form of diltiazem|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP56197358A|JPS6317832B2|1981-12-07|1981-12-07|
    [返回顶部]